D. Mischoulon

J. Lake, S. Seedat, S. Kasper, 2022, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The use of natural remedies in psychiatry: a commentary.

J. Rosenbaum, D. Mischoulon, 1999, Harvard review of psychiatry.

Increased risk of depression before and after unilateral or bilateral oophorectomy: A self-controlled case series study using a nationwide cohort in South Korea.

M. Fava, Yuwon Kim, H. Jeon, 2021, Journal of affective disorders.

Early psychiatric referral after attempted suicide helps prevent suicide reattempts: A longitudinal national cohort study in South Korea

M. Fava, Yuwon Kim, H. Jeon, 2022, Frontiers in Psychiatry.

Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.

M. Fava, A. Nierenberg, J. Rosenbaum, 2005, The international journal of neuropsychopharmacology.

Quantifying and addressing the impact of measurement error in network models.

Donald J. Robinaugh, S. Epskamp, E. Fried, 2022, Behaviour research and therapy.

Celebrity Suicides and Their Differential Influence on Suicides in the General Population: A National Population-Based Study in Korea

M. Fava, H. Won, H. Jeon, 2015, Psychiatry investigation.

Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.

M. Fava, D. Mischoulon, G. Papakostas, 2010, The Journal of clinical psychiatry.

Effects of Electroacupuncture for Depression-Related Insomnia.

D. Mischoulon, A. Yeung, 2022, JAMA network open.

Interleukin-6 receptor antagonists in immunopsychiatry: Can they lead to increased interleukin-6 in the central nervous system (CNS) and worsening psychiatric symptoms?

D. Mischoulon, C. Raison, M. Nyer, 2022, Brain, Behavior, and Immunity.

Docosahexanoic acid and omega-3 fatty acids in depression.

D. Mischoulon, M. Fava, 2000, The Psychiatric clinics of North America.

Does folic acid interfere with lamotrigine?

M. Fava, J. Zajecka, D. Mischoulon, 2016, The lancet. Psychiatry.

growth response transcription factors . immediate-earlyexpression of C / EBP alpha and differentiation in rat hepatocytes : reciprocal regulate the switch between growth and Cell-extracellular matrix interactions can

D. Mischoulon, S. Farmer, N. Bucher, 2022 .

An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding

M. Fava, A. Fischman, D. Dougherty, 2002, Psychiatry Research: Neuroimaging.

Differences in cognitive factors between “true drug” versus “placebo pattern” response to fluoxetine as defined by pattern analysis

M. Fava, D. Mischoulon, G. Papakostas, 2006, Human psychopharmacology.

Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder

M. Fava, J. Stewart, P. McGrath, 2008, Psychiatry Research.

High body weight variability is associated with increased risk of depression: a nationwide cohort study in South Korea

M. Fava, H. Jeon, D. Mischoulon, 2022, Psychological Medicine.

Association between pre-pregnancy tobacco smoking and postpartum depression: A nationwide cohort study.

M. Fava, H. Jeon, D. Mischoulon, 2022, Journal of affective disorders.

The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause

Nhi-Ha T. Trinh, M. Fava, C. Cusin, 2019, Psychoneuroendocrinology.

CBT Delivered in a Specialized Depression Clinic for College Students with Depressive Symptoms

M. Fava, B. Shapero, D. Holt, 2018, Journal of Rational-Emotive & Cognitive-Behavior Therapy.

A Double‐Blind, Randomized, Pilot Dose‐Finding Study of Maca Root (L. Meyenii) for the Management of SSRI‐Induced Sexual Dysfunction

M. Fava, D. Mischoulon, G. Papakostas, 2008, CNS neuroscience & therapeutics.

Cranial Electrotherapy Stimulation (CES) for Major Depressive Disorder

D. Mischoulon, P. Cassano, Aura M. Hurtado, 2022, Psychiatric Annals.

Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study.

M. Fava, C. Cusin, D. Dougherty, 2015, Journal of psychiatric research.

Reported Side Effects, Weight and Blood Pressure, After Repeated Sessions of Transcranial Photobiomodulation.

Michael R Hamblin, Nhi-Ha T. Trinh, M. Hamblin, 2019, Photobiomodulation, photomedicine, and laser surgery.

Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial.

Luis De Taboada, Michael R Hamblin, Paolo Cassano, 2018, Photomedicine and laser surgery.

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study

Michael R. Hamblin, Luis De Taboada, Michael R Hamblin, 2015, Psychiatry journal.

Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study

M. Fava, M. Trivedi, C. Cusin, 2020, Depression and anxiety.

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

M. Pencina, M. Fava, M. Pollack, 2012, Psychotherapy and Psychosomatics.

A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder.

M. Fava, D. Mischoulon, A. Yeung, 2011, Journal of affective disorders.

Mindfulness-Based Cognitive Therapy Improves Cognitive Functioning and Flexibility Among Individuals with Elevated Depressive Symptoms

S. Lazar, B. Shapero, D. Mischoulon, 2018, Mindfulness.

Mindfulness-Based Cognitive Therapy Improves Cognitive Functioning and Flexibility Among Individuals with Elevated Depressive Symptoms

Benjamin G. Shapero, S. Lazar, B. Shapero, 2018, Mindfulness.

Mindfulness-based cognitive therapy for depressed individuals improves suppression of irrelevant mental-sets

Benjamin G. Shapero, S. Lazar, B. Shapero, 2016, European Archives of Psychiatry and Clinical Neuroscience.

Paraquat Prohibition and Change in the Suicide Rate and Methods in South Korea

M. Fava, H. Won, H. Jeon, 2015, PloS one.

Telomere length and its relationships with lifestyle and behavioural factors: variations by sex and race/ethnicity.

J. Manson, N. Cook, C. Reynolds, 2020, Age and ageing.

A Double-Blind Placebo-Controlled Trial of Maca Root as Treatment for Antidepressant-Induced Sexual Dysfunction in Women

Elizabeth D. Dalton, M. Fava, P. Schettler, 2015, Evidence-based complementary and alternative medicine : eCAM.

St John’s Wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26-Week RCT

D. Mischoulon, J. Sarris, I. Schweitzer, 2012, Pharmacopsychiatry.

The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.

A. Nierenberg, P. Schettler, R. Howland, 2011, Journal of psychiatric research.

Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.

Maurizio Fava, M. Fava, D. Mischoulon, 2002, The American journal of clinical nutrition.

Second-tier natural antidepressants: review and critique.

Elizabeth D Dalton, Maurizio Fava, Elizabeth D. Dalton, 2011, Journal of affective disorders.

Depression and eating disorders: treatment and course.

D. Franko, D. Mischoulon, D. Herzog, 2011, Journal of affective disorders.

Complementary and Alternative Medicine in Major Depressive Disorder

M. Fava, D. Mischoulon, G. Papakostas, 2009 .

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.

J. Lake, A. Stoll, P. Keck, 2006, The Journal of clinical psychiatry.

Nutritional medicine as mainstream in psychiatry.

A. Scholey, D. Mischoulon, A. Sánchez-Villegas, 2015, The lancet. Psychiatry.

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

Elizabeth D. Dalton, R. Shelton, M. Pencina, 2012, The American journal of psychiatry.

Personalized Medicine

Simmie L. Foster, M. Fava, D. Mischoulon, 2018, The Massachusetts General Hospital Guide to Depression.

Folate in depression: efficacy, safety, differences in formulations, and clinical issues.

M. Fava, D. Mischoulon, 2010, The Journal of clinical psychiatry.

S0033291720000112jra 1355..1363

M. Fava, M. Trivedi, C. Cusin, 2021 .

Anger attacks are associated with persistently elevated irritability in MDD: findings from the EMBARC study

M. Fava, M. Trivedi, C. Cusin, 2020, Psychological Medicine.

Loss of sexual interest and premenstrual mood change in women with postpartum versus non-postpartum depression: A nationwide community sample of Korean adults.

M. Fava, H. Jeon, D. Mischoulon, 2016, Journal of affective disorders.

Diet and depression: exploring the biological mechanisms of action

C. Pariante, A. O'Neil, M. Berk, 2020, Molecular Psychiatry.

Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment

M. Fava, A. Nierenberg, J. Alpert, 2012, CNS Spectrums.

Circulating microRNAs as biomarkers for depression: Many candidates, few finalists.

M. Fava, M. Otto, D. Mischoulon, 2017, Journal of affective disorders.

Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors

D. Mischoulon, S. Farmer, N. Bucher, 1994, Molecular and cellular biology.

A randomized controlled dosing study of Iyengar yoga and coherent breathing for the treatment of major depressive disorder: Impact on suicidal ideation and safety findings.

M. Fava, D. Mischoulon, T. Scott, 2018, Complementary therapies in medicine.

What is the role of alternative treatments in late-life depression?

James D. Doorley, D. Mischoulon, A. Yeung, 2013, The Psychiatric clinics of North America.

Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report.

J. Lake, M. Fava, M. Trivedi, 2010, The Journal of clinical psychiatry.

Risks of suicide attempts after prescription of zolpidem in people with depression: A nationwide population study in South Korea.

M. Fava, Hyosang Lee, Yuwon Kim, 2020, Sleep.

Pilot study of DNA methylation, molecular aging markers and measures of health and well-being in aging

J. Manson, C. Reynolds, Shun-Chiao Chang, 2019, Translational Psychiatry.

College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity.

M. Fava, J. Alpert, D. Holt, 2015, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

S-Adenosyl-L-Methionine (SAMe) as an Adjunct for Resistant Major Depressive Disorder: An Open Trial Following Partial or Nonresponse to Selective Serotonin Reuptake Inhibitors or Venlafaxine

M. Fava, A. Nierenberg, J. Alpert, 2004, Journal of clinical psychopharmacology.

S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life

M. Fava, J. Roffman, Xudong Huang, 2018, Neurotherapeutics.

Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial

M. Fava, L. Price, L. Carpenter, 2015, Pharmacopsychiatry.

S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response.

M. Fava, O. Vitolo, D. Mischoulon, 2014, Journal of affective disorders.

A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.

M. Fava, L. Baer, L. Price, 2014, The Journal of clinical psychiatry.

SAMe and sexual functioning

J. Alpert, D. Mischoulon, G. Papakostas, 2012, European Psychiatry.

S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.

M. Fava, J. Alpert, D. Mischoulon, 2010, The American journal of psychiatry.

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial

M. Berk, D. Mischoulon, C. Stough, 2019, Psychopharmacology.

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial,

M. Berk, D. Mischoulon, C. Stough, 2018, European Neuropsychopharmacology.

International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder

M. Maes, C. Pariante, M. Berk, 2019, Psychotherapy and Psychosomatics.

Inflammation as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: A Proof of Concept Study

A. Nierenberg, P. Schettler, D. Mischoulon, 2015, Molecular Psychiatry.

The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.

B. Lebowitz, M. Fava, A. Nierenberg, 2005, The international journal of neuropsychopharmacology.

Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.

M. Fava, A. Nierenberg, J. Rosenbaum, 2004, The Journal of clinical psychiatry.

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study

M. Fava, J. Lee, H. Jeon, 2017, Psychiatry investigation.

Prospective association between major depressive disorder and leukocyte telomere length over two years

M. Fava, N. Simon, D. Mischoulon, 2018, Psychoneuroendocrinology.

Acupuncture for Depression: A Review of Clinical Applications

Junmei Wu, D. Mischoulon, A. Yeung, 2012, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

PREDICTORS OF STABLE PERSONALITY DISORDER DIAGNOSES IN OUTPATIENTS WITH REMITTED DEPRESSION

M. Fava, J. Alpert, D. Mischoulon, 2002, The Journal of nervous and mental disease.

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

M. Fava, A. Nierenberg, R. Perlis, 2005, The Journal of clinical psychiatry.

Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians

M. Fava, A. Nierenberg, J. Rosenbaum, 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.

E. Brown, M. Fava, C. Cusin, 2016, The Journal of clinical psychiatry.

Reduced orbitofrontal-thalamic functional connectivity related to suicidal ideation in patients with major depressive disorder

M. Fava, C. E. Han, S. Seo, 2017, Scientific Reports.

Quality of life assessments in major depressive disorder: a review of the literature.

Maurizio Fava, George I Papakostas, M. Fava, 2004, General hospital psychiatry.

Atypical psychotic symptoms in a Hispanic population: diagnostic dilemmas and implications for treatment.

D. Mischoulon, Christy Harmon, I. Lagomasino, 2005, Psychiatry (Edgmont (Pa. : Township)).

Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression

D. Mischoulon, M. Caldieraro, S. Leistner-Segal, 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators

M. Fava, P. Schettler, B. Dunlop, 2023, Neuropsychopharmacology.

Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder

M. Fava, H. Jeon, D. Mischoulon, 2018, Psychiatry Research.

The Massachusetts General Hospital Guide to Depression

Benjamin G. Shapero, C. Cusin, B. Shapero, 2019, Current Clinical Psychiatry.

Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison.

M. Fava, B. Yu, H. Jeon, 2017, Journal of psychiatric research.

Follicle-stimulating hormone (FSH), current suicidal ideation and attempt in female patients with major depressive disorder

M. Fava, B. Yu, H. Jeon, 2013, Psychiatry Research.

The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder

M. Fava, A. Nierenberg, D. Mischoulon, 2009, Nordic journal of psychiatry.

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

M. Fava, J. Rosenbaum, J. Smoller, 2003, Biological Psychiatry.

Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder.

M. Fava, C. Cusin, L. Price, 2019, Journal of affective disorders.

Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.

J. Manson, N. Cook, J. Buring, 2021, JAMA.

Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder: The ELATED-3 Multicenter, Randomized, Sham-Controlled Trial.

Michael R Hamblin, C. Cusin, D. Mischoulon, 2022, The Journal of clinical psychiatry.

Lifestyle and behavioral factors and mitochondrial DNA copy number in a diverse cohort of mid-life and older adults

J. Manson, N. Cook, C. Reynolds, 2020, PLoS ONE.

A Patient With Electroconvulsive Therapy-resistant Major Depressive Disorder With a Full Response to Heated Yoga: A Case Report.

M. Fava, D. Mischoulon, C. Streeter, 2021, Journal of psychiatric practice.

Community-Delivered Heated Hatha Yoga as a Treatment for Depressive Symptoms: An Uncontrolled Pilot Study.

M. Fava, J. Alpert, D. Mischoulon, 2019, Journal of alternative and complementary medicine.

Low-dose Transdermal Testosterone Augmentation Therapy Improves Depression Severity in Women

M. Fava, R. Perlis, D. Mischoulon, 2009, CNS Spectrums.

An Approach to the Patient Seeking Psychiatric Disability Benefits

D. Mischoulon, 1999 .

Inflammatory cytokines in major depressive disorder: A case–control study

M. Fava, N. Simon, J. Alpert, 2017, The Australian and New Zealand journal of psychiatry.

Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression

M. Fava, L. Baer, L. Price, 2018, Front. Psychiatry.

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation

Trina E. Chang, E. Brown, M. Fava, 2017, The Australian and New Zealand journal of psychiatry.

Phase IIb Trial of an &agr;7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence

Gladys N. Pachas, M. Fava, D. Schoenfeld, 2018, Journal of clinical psychopharmacology.

Transfer to a New Psychopharmacologist

J. Rosenbaum, D. Mischoulon, E. Messner, 2000 .

The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.

M. Fava, A. Nierenberg, D. Mischoulon, 2002, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

DETAILED STUDY PROTOCOL TITLE: Omega-3 Fatty Acids for MDD with High Inflammation: A Personalized Approach

M. Fava, Principal Investigators, D. Mischoulon, 2019 .

The effect of sildenafil on quality of life.

M. Fava, M. Trivedi, S. Wisniewski, 2013, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Association of Race and Ethnicity With Late-Life Depression Severity, Symptom Burden, and Care.

J. Manson, N. Cook, C. Reynolds, 2020, JAMA network open.

Prevalence of major depressive disorder among Chinese-Americans in primary care.

M. Fava, A. Nierenberg, D. Mischoulon, 2004, General hospital psychiatry.

Major depressive disorder with psychosis-like symptoms among Latinos.

M. Fava, D. Mischoulon, P. Cassano, 2012, Psychiatric services.

Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression

Britta K. Hölzel, A. Sack, T. Gard, 2016, Front. Psychol..

An adjunctive antidepressant nutraceutical combination in treating major depression: Study protocol, and clinical considerations

M. Berk, D. Mischoulon, C. Stough, 2015 .

Acupuncture for major depressive disorder: has its efficacy been disproved?

M. Fava, J. Alpert, D. Mischoulon, 2007, The Journal of clinical psychiatry.

Protocol for studying racial/ethnic disparities in depression care using joint information from participant surveys and administrative claims databases: an observational cohort study

J. Manson, C. Reynolds, D. Mischoulon, 2020, BMJ Open.

Does Psychiatry Residency Training Reflect the “Real World” of Psychiatry Practice? A Survey of Residency Graduates

M. Fava, J. Alpert, D. Mischoulon, 2007, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

Comparison of treatment selections by Japanese and US psychiatrists for major depressive disorder: A case vignette study

M. Mimura, A. Nakagawa, D. Mischoulon, 2015, Psychiatry and clinical neurosciences.

Comparison of Initial Psychological Treatment Selections by US and Japanese Early-Career Psychiatrists for Patients with Major Depression: A Case Vignette Study

M. Mimura, A. Nakagawa, D. Mischoulon, 2015, Academic Psychiatry.

Compassionate Hearts Protect Against Wandering Minds: Self-Compassion Moderates the Effect of Mind-Wandering on Depression

Benjamin G. Shapero, S. Lazar, B. Shapero, 2018, Spirituality in clinical practice.

RELATIONSHIP BETWEEN SLEEP DISTURBANCE AND DEPRESSION, ANXIETY, AND FUNCTIONING IN COLLEGE STUDENTS

M. Fava, D. Holt, O. Vitolo, 2013, Depression and anxiety.

Needing Too Much: Managing Crises in a Patient with Dependent Personality Traits.

R. Bornstein, D. Mischoulon, B. Unruh, 2020, Harvard review of psychiatry.

Screening for Suicide Risk in the College Population

M. Fava, A. Nierenberg, C. Cusin, 2015 .

Multiple types of somatic pain increase suicide attempts and depression: A nationwide community sample of Korean adults.

M. Fava, H. Jeon, D. Mischoulon, 2019, Comprehensive psychiatry.

Cross-national differences in hypochondriasis symptoms between Korean and American outpatients with major depressive disorder

M. Fava, H. Jeon, D. Mischoulon, 2016, Psychiatry Research.

Differences in depressive symptoms between Korean and American outpatients with major depressive disorder

M. Fava, L. Baer, H. Jeon, 2014, International clinical psychopharmacology.

Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)

R. Shelton, M. Fava, M. Trivedi, 2018, Brain Stimulation.

Potential Pitfalls to the Therapeutic Relationship Arising From Disability Claims

D. Mischoulon, 2002 .

Psychoticism and Paranoid Ideation in Patients With Nonpsychotic Major Depressive Disorder: Prevalence, Response to Treatment, and Impact on Short- and Long-Term Treatment Outcome

M. Fava, A. Nierenberg, J. Stewart, 2010, CNS Spectrums.

Diagnosis and Monitoring Depression View project Clinical Studies : Cooling and Omega-3 fatty Acids View project

Elizabeth D. Dalton, M. Fava, D. Mischoulon, 2010 .

A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.

R. Shelton, M. Fava, D. Schoenfeld, 2012, The Journal of clinical psychiatry.

PS153. Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial

James D. Doorley, M. Fava, L. Baer, 2015, Journal of psychiatric research.

Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial

James D. Doorley, M. Fava, L. Baer, 2014, International clinical psychopharmacology.

L-methylfolate augmentation of selective serotonin reuptake inhibitors (SSRIS) for major depressive disorder: Results of two randomized, double-blind trials

S. Zisook, J. Alpert, L. Baer, 2011, European psychiatry.

Bullying, Psychological, and Physical Trauma During Early Life Increase Risk of Major Depressive Disorder in Adulthood: A Nationwide Community Sample of Korean Adults

M. Fava, H. Jeon, D. Mischoulon, 2022, Frontiers in Psychiatry.

A Double-Blind, Placebo-Controlled Trial of the NMDA Glycine Site Antagonist, GW468816, for Prevention of Relapse to Smoking in Females

Gladys N. Pachas, M. Fava, N. Rigotti, 2011, Journal of clinical psychopharmacology.

Improvement in Subjective and Objective Neurocognitive Functions in Patients With Major Depressive Disorder: A 12-Week, Multicenter, Randomized Trial of Tianeptine Versus Escitalopram, the CAMPION Study

M. Fava, Seung-Hwan Lee, B. Yu, 2014, Journal of clinical psychopharmacology.

Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder.

M. Fava, A. Nierenberg, H. Jeon, 2015, Journal of affective disorders.

Deformities of the Globus Pallidus are Associated with Severity of Suicidal Ideation and Impulsivity in Patients with Major Depressive Disorder

M. Fava, S. Seo, H. Jeon, 2019, Scientific Reports.

Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.

M. Fava, Seung-Hwan Lee, H. Jeon, 2015, Journal of affective disorders.

Complementary Medicine, Exercise, Meditation, Diet, and Lifestyle Modification for Anxiety Disorders: A Review of Current Evidence

M. Berk, D. Mischoulon, D. Camfield, 2012, Evidence-based complementary and alternative medicine : eCAM.

Frontal EEG predictors of treatment outcome in major depressive disorder

Maurizio Fava, Dan V. Iosifescu, M. Fava, 2009, European Neuropsychopharmacology.

Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.

M. Pencina, M. Fava, M. Pollack, 2012, The Journal of clinical psychiatry.

37 – Complementary Medicine and Natural Medications

D. Mischoulon, F. Smith, 2010 .

Four-Week Mentalizing Imagery Therapy for Family Dementia Caregivers: A Randomized Controlled Trial with Neural Circuit Changes

C. Cusin, L. Nickerson, F. Jain, 2022, Psychotherapy and Psychosomatics.

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.

M. Fava, C. Cusin, D. Ionescu, 2017, Journal of affective disorders.

The Herbal Anxiolytics Kava and Valerian for Anxiety and Insomnia

D. Mischoulon, 2002 .

Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.

J. Manson, N. Cook, J. Buring, 2020, JAMA.

Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group.

M. Fava, C. Cusin, L. Baer, 2015, Asian journal of psychiatry.

Deficits in Psychological Well‐Being and Quality‐of‐Life in Minor Depression: Implications for DSM‐V

A. Nierenberg, P. Schettler, R. Howland, 2010, CNS neuroscience & therapeutics.

Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.

M. Fava, A. Nierenberg, J. Alpert, 2003, Comprehensive psychiatry.

Associations Between Smoking, Alcohol Consumption, Physical Activity and Depression in Middle-Aged Premenopausal and Postmenopausal Women

M. Fava, H. Jeon, D. Mischoulon, 2021, Frontiers in Psychiatry.

Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties

M. Fava, A. Holmes, D. Dougherty, 2014, Psychological Medicine.

A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.

M. Fava, L. Baer, D. Mischoulon, 2012, Journal of clinical psychopharmacology.

Mixed Effects Random Forests for Personalised Predictions of Clinical Depression Severity

Rosalind W. Picard, Asma Ghandeharioun, Szymon Fedor, 2023, ArXiv.

Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review.

Simmie L. Foster, M. Fava, C. Cusin, 2020, Journal of affective disorders.

Cultural Issues in the Management of Depression Among Chinese Americans

D. Mischoulon, A. Yeung, Doga Cetinkaya, 2023, Psychiatric Annals.

Binge eating, trauma, and suicide attempt in community adults with major depressive disorder

M. Fava, H. Jeon, D. Mischoulon, 2018, PloS one.

Depressed Chinese Americans present predominantly psychological symptoms: A new trend or different outcomes due to methodological differences?

D. Mischoulon, A. Yeung, C. Borba, 2021, Asian journal of psychiatry.

“The Matrix”: An Allegory of the Psychoanalytic Journey

D. Mischoulon, E. Beresin, 2004, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

Effect of Korean Red Ginseng in individuals exposed to high stress levels: a 6-week, double-blind, randomized, placebo-controlled trial

M. Fava, H. Jeon, D. Mischoulon, 2018, Journal of ginseng research.

Relationships between major depressive disorder and comorbid anxiety and personality disorders.

M. Fava, J. Alpert, D. Mischoulon, 2005, Comprehensive psychiatry.

Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report.

M. Fava, D. Mischoulon, G. Sanacora, 2013, Psychosomatics.

Anger Attacks in Major Depressive Disorder and Serum Levels of Homocysteine

M. Fava, J. Alpert, D. Mischoulon, 2006, Biological Psychiatry.

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.

E. Brown, M. Fava, C. Cusin, 2019, Journal of affective disorders.

Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder

M. Fava, A. Nierenberg, H. Jeon, 2016, Psychiatry investigation.

Design and Methods of the Korean National Investigations of 70,000 Suicide Victims Through Police Records (The KNIGHTS Study)

M. Fava, H. Jeon, D. Mischoulon, 2019, Psychiatry investigation.

Does the association between Herpes Simplex 2 infection and depressive symptoms vary among different sexual minority statuses and sex groups? Findings from a nationally representative sample.

D. Mischoulon, M. Nyer, Junjie Lu, 2023, Journal of affective disorders.

Tachyphylaxis in major depressive disorder: A review of the current state of research.

M. Fava, A. Nierenberg, D. Mischoulon, 2019, Journal of affective disorders.

Building an evidence base in complementary and integrative healthcare for child and adolescent psychiatry.

E. Edwards, D. Mischoulon, W. Weber, 2013, Child and adolescent psychiatric clinics of North America.

Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.

M. Fava, A. Nierenberg, H. Jeon, 2014, Journal of affective disorders.

Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression-Reply.

J. Manson, D. Mischoulon, O. Okereke, 2022, JAMA.

A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder.

M. Maes, C. Pariante, M. Berk, 2020, Journal of affective disorders.

Internet Game Addiction, Depression, and Escape From Negative Emotions in Adulthood: A Nationwide Community Sample of Korea

M. Fava, H. Jeon, D. Mischoulon, 2017, The Journal of nervous and mental disease.

Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day

M. Fava, A. Nierenberg, J. Rosenbaum, 2003, Acta psychiatrica Scandinavica.

Comparisons of Subthreshold Versus Full Posttraumatic Stress Disorder Distinguished by Subjective Functional Impairment Among Train Drivers: A Population-Based Nationwide Study in South Korea

Seung Jin Park, M. Fava, H. Jeon, 2016, Psychiatry investigation.

Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire.

Trina E. Chang, M. Desseilles, M. Fava, 2011, The Journal of clinical psychiatry.

Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI

M. Fava, D. Mischoulon, Stella Bitran, 2011, International clinical psychopharmacology.

Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults.

J. Manson, D. Blacker, R. Sadreyev, 2023, Journal of Alzheimer's disease : JAD.

Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment.

M. Fava, L. Baer, D. Mischoulon, 2010, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

The overlap between personality disorders and major depressive disorder (MDD).

M. Fava, J. Alpert, D. Mischoulon, 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Report of Two Double‐Blind Randomized Placebo‐Controlled Pilot Studies of a Carbohydrate‐Rich Nutrient Mixture for Treatment of Seasonal Affective Disorder (SAD)

M. Vangel, R. Wurtman, D. Mischoulon, 2010, CNS neuroscience & therapeutics.

Major depressive disorder and insomnia: Exploring a hypothesis of a common neurological basis using waking and sleep-derived heart rate variability.

D. Mischoulon, K. Bentley, J. Winkelman, 2020, Journal of psychiatric research.

Anxiety attacks with or without life-threatening situations, major depressive disorder, and suicide attempt: a nationwide community sample of Korean adults

M. Fava, H. Jeon, D. Mischoulon, 2018, Psychiatry Research.

Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder

M. Fava, A. Nierenberg, B. Yu, 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study.

M. Fava, H. Jeon, D. Mischoulon, 2019, Comprehensive psychiatry.

A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: Comparing patients who recently discontinued an ssri with those on no recent antidepressant treatment

M. Fava, J. Rosenbaum, D. Mischoulon, 2004, Depression and anxiety.

Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment

Simmie L. Foster, M. Fava, C. Cusin, 2022, Journal of clinical psychopharmacology.

Current Role of Herbal and Natural Preparations.

D. Mischoulon, M. Rapaport, 2019, Handbook of experimental pharmacology.

Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients

D. Mischoulon, J. Chang, K. Su, 2023, Journal of personalized medicine.

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial.

M. Fava, A. Nierenberg, P. Schettler, 2022, The Journal of clinical psychiatry.

Effectiveness of Mindful Self-Compassion Training Supported by Online Peer Groups in China: A Pilot Study.

X. Mai, F. Jain, D. Mischoulon, 2021, Alternative therapies in health and medicine.

The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression

M. Pencina, M. Fava, D. Mischoulon, 2013, International clinical psychopharmacology.

Massachusetts General Hospital SAFER Criteria for Clinical Trials and Research

Trina E. Chang, M. Desseilles, M. Fava, 2013, Harvard review of psychiatry.

D. Mischoulon, 2018, Focus.

A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression.

A. Nierenberg, P. Schettler, D. Mischoulon, 2015, The Journal of clinical psychiatry.

Childhood trauma and platelet brain-derived neurotrophic factor (BDNF) after a three month follow-up in patients with major depressive disorder.

H. Jeon, D. Mischoulon, Dongsoo Lee, 2012, Journal of psychiatric research.

Lifetime suicidal ideation and attempt in adults with full major depressive disorder versus sustained depressed mood.

M. Fava, H. Jeon, D. Mischoulon, 2016, Journal of affective disorders.

Risks of Completed Suicide of Community Individuals with ICD-10 Disorders Across Age Groups: A Nationwide Population-Based Nested Case-Control Study in South Korea

M. Fava, H. Jeon, D. Mischoulon, 2019, Psychiatry investigation.

Title Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression Permalink

Britta K. Hölzel, A. Sack, T. Gard, 2016 .

Comparison of suicide attempts in individuals with major depressive disorder with and without history of subthreshold hypomania: A nationwide community sample of Korean adults✰,✰✰.

M. Fava, H. Jeon, D. Mischoulon, 2019, Journal of affective disorders.

The combination of duloxetine and bupropion for treatment‐resistant major depressive disorder

M. Fava, D. Mischoulon, J. Worthington, 2006, Depression and anxiety.

Paranoid Ideation Without Psychosis Is Associated With Depression, Anxiety, and Suicide Attempts in General Population.

M. Fava, H. Jeon, D. Mischoulon, 2019, The Journal of nervous and mental disease.

Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice.

M. Fava, J. Rosenbaum, D. Mischoulon, 1999, Harvard review of psychiatry.

Predictive inflammatory biomarkers for change in suicidal ideation in major depressive disorder and panic disorder: A 12-week follow-up study.

M. Fava, H. Jeon, D. Mischoulon, 2020, Journal of psychiatric research.

Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive Disorder

M. Fava, Jong Woo Kim, H. Jeon, 2016, Psychiatry investigation.

Ages at menarche and menopause, hormone therapy, and the risk of depression.

M. Fava, H. Jeon, D. Mischoulon, 2023, General Hospital Psychiatry.

Alcohol-induced disinhibition is associated with impulsivity, depression, and suicide attempt: A nationwide community sample of Korean adults.

M. Fava, H. Jeon, D. Mischoulon, 2018, Journal of affective disorders.

Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia

M. Fava, H. Jeon, D. Mischoulon, 2020, Frontiers in Psychiatry.

Metabolic Syndrome in Dutch Patients With Bipolar Disorder: A Cross-Sectional Study.

T. Gard, D. Mischoulon, F. Peeters, 2018, The primary care companion for CNS disorders.

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized Controlled Trial in Major Depressive Disorder

M. Fava, J. Alpert, D. Mischoulon, 2014 .

High Bodyweight Variability Increases Depression Risk in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study in Korea

M. Fava, D. Shin, H. Jeon, 2021, Frontiers in Psychiatry.

The Pharmacologic Management of SSRI-Induced Side Effects: A Survey of Psychiatrists

M. Fava, A. Nierenberg, J. Rosenbaum, 2002 .

CBT Delivered in a Specialized Depression Clinic for College Students with Depressive Symptoms

Benjamin G. Shapero, M. Fava, B. Shapero, 2018, Journal of Rational-Emotive & Cognitive-Behavior Therapy.

Virtual mentalizing imagery therapy for Spanish language Latino family dementia caregivers: A feasibility and acceptability study

F. Jain, Julene K. Johnson, D. Mischoulon, 2023, Frontiers in Psychology.

In fl ammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder : a proof-of-concept study

D. Mischoulon, B. Kinkead, A. Nierenberg, 2015 .

Folinic Acid (Leucovorin) as an Adjunctive Treatment for SSRI-Refractory Depression

Maurizio Fava, Andrew A. Nierenberg, M. Fava, 2002 .

Commentary on "Accelerated DNA Methylation Aging in U.S. Military Veterans: Results From the National Health and Resilience in Veterans Study".

D. Mischoulon, 2019, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Aggregating heart rate variability indices across sleep stage epochs ignores significant variance through the night.

D. Mischoulon, K. Bentley, J. Winkelman, 2022, Sleep medicine.

Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms

Nhi-Ha T. Trinh, Trina E. Chang, C. Cusin, 2015, The Journal of nervous and mental disease.

Major depressive disorder with psychosis-like symptoms in Latinos: treatment with and without antipsychotic augmentation

Nhi-Ha T. Trinh, Trina E. Chang, M. Fava, 2015 .

Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos.

Nhi-Ha T. Trinh, Trina E. Chang, M. Fava, 2013, Journal of affective disorders.

In Latinos with major depressive disorder, do ‘soft psychotic’ symptoms merit augmentation with atypical antipsychotics?

Nhi-Ha T. Trinh, Trina E. Chang, D. Mischoulon, 2014 .

The descriptive analysis of depressive symptoms and White Blood Cell (WBC) count between the sexual minorities and heterosexual identifying individuals in a nationally representative sample: 2005–2014

D. Mischoulon, M. Nyer, Junjie Lu, 2023, BMC Public Health.

The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD)

J. Alpert, D. Mischoulon, A. Farabaugh, 2004, Acta psychiatrica Scandinavica.

Association of smartphone overuse with depression, anxiety, and other addictive behaviors: A nationwide community sample of Korean adults

M. Fava, H. Jeon, D. Mischoulon, 2021, Psychiatry Research.

Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial

M. Fava, P. Schettler, B. Dunlop, 2023, Brain, behavior, & immunity - health.

A pilot study of acupuncture monotherapy in patients with major depressive disorder.

M. Fava, D. Mischoulon, A. Yeung, 2012, Journal of affective disorders.

Outcomes of Recognizing Depressed Chinese American Patients in Primary Care

M. Fava, A. Nierenberg, J. Alpert, 2005, International journal of psychiatry in medicine.

An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.

M. Fava, D. Mischoulon, C. Dording, 2002, The Journal of clinical psychiatry.

Sleep quality, posttraumatic stress, depression, and human errors in train drivers: a population-based nationwide study in South Korea.

Hong Jin Jeon, Sungwon Roh, Maurizio Fava, 2014, Sleep.

A Brief Review on the Potential of Psychedelics for Treating Alzheimer’s Disease and Related Depression

Simmie L. Foster, M. Fava, D. Mischoulon, 2023, International journal of molecular sciences.

A Patient with Treatment-resistant Depression Who Achieved Remission with Heated Yoga: A Case Report

Simmie L. Foster, M. Fava, C. Cusin, 2021, Clinical Neuropsychopharmacology and Therapeutics.

Yoga for the treatment of depression: Five questions to move the evidence-base forward.

D. Mischoulon, C. Streeter, L. Uebelacker, 2019, Complementary therapies in medicine.

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

M. Fava, N. Makris, B. Dickerson, 2015, Molecular Psychiatry.

Comparison of Academic and Nonacademic Sites in Multi-Center Clinical Trials

Elizabeth D. Dalton, M. Pencina, M. Fava, 2012, Journal of clinical psychopharmacology.

Rising early warning signals in affect associated with future changes in depression: a dynamical systems approach

Rosalind W. Picard, C. Cusin, Szymon Fedor, 2021, Psychological Medicine.

Childhood parental death and lifetime suicide attempt of the opposite-gender offspring in a nationwide community sample of Korea.

M. Fava, H. Jeon, D. Mischoulon, 2013, Suicide & life-threatening behavior.

A Randomized Controlled Pilot Study on Mindfulness-Based Cognitive Therapy for Unipolar Depression in Patients With Chronic Pain.

James D. Doorley, M. Fava, T. Gard, 2017, The Journal of clinical psychiatry.

Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression

D. Mischoulon, M. Caldieraro, S. Leistner-Segal, 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Inflammatory cytokines in major depressive disorder: A case–control study

M. Fava, N. Simon, J. Alpert, 2017, The Australian and New Zealand journal of psychiatry.

Longer-term open-label study of adjunctive riluzole in treatment-resistant depression.

Simmie L. Foster, Nhi-Ha T. Trinh, Trina E. Chang, 2019, Journal of affective disorders.

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.

M. Fava, C. Cusin, D. Ionescu, 2017, Journal of affective disorders.

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.

E. Brown, M. Fava, C. Cusin, 2019, Journal of affective disorders.

Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study

Emily M Hahn, Trina E. Chang, Benjamin G. Shapero, 2020 .

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses.

M. Fava, M. Berk, D. Mischoulon, 2016, The American journal of psychiatry.

St John’s Wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26-Week RCT

D. Mischoulon, Maurizio Fava, Isaac Schweitzer, 2012, Pharmacopsychiatry.

Relation of serum BDNF to major depression and exploration of mechanistic roles of serum BDNF in a study of vitamin D3 and omega-3 supplements for late-life depression prevention.

J. Manson, N. Cook, N. Rifai, 2023, Journal of psychiatric research.

Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder

M. Fava, C. E. Han, S. Seo, 2016, Translational psychiatry.

Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder

M. Fava, A. Nierenberg, B. Yu, 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Childhood parental death and lifetime suicide attempt of the opposite-gender offspring in a nationwide community sample of Korea.

M. Fava, D. Mischoulon, J. Sohn, 2013, Suicide & life-threatening behavior.

Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.

M. Fava, D. Mischoulon, E. Jang, 2019, Journal of affective disorders.

Omega-3 fatty acids in psychiatry.

D. Mischoulon, M. Freeman, 2013, The Psychiatric clinics of North America.

Obsessive Thought, Compulsive Behavior, and Their Associations With Suicide Ideation and Attempts and Major Depressive Disorder

M. Fava, D. Mischoulon, J. Hong, 2021, The Journal of nervous and mental disease.

All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment.

Simmie L. Foster, M. Fava, C. Cusin, 2020, The American journal of psychiatry.

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder

M. Fava, A. Nierenberg, J. Alpert, 2008, European Neuropsychopharmacology.